This report describes three patients in whom colonoscopy detected small depressed cancers (without an elevated component) that had invaded the submucosa. They represent 0.4% (3/884) of all patients with invasive cancers and 3% (3/101) of patients with submucosal cancers in the National Cancer Center Hospital between January 1990 and February 1994. This type of cancer may have been overlooked in the past because of its small, flat nature. A slight deformity of the lumen, a faint color change (slightly reddish), and a loss of a vascular network pattern were important colonoscopic findings. Small depressed cancers may follow a different pathway to advanced cancer than polypoid cancers, although both pathways are included in the adenoma-carcinoma sequence. We should be aware of these lesions in our efforts to detect colorectal cancers in the early stage.

Download full-text PDF

Source

Publication Analysis

Top Keywords

small depressed
12
depressed cancers
8
cancers
6
small
4
cancer
4
depressed cancer
4
cancer large
4
large bowel
4
bowel report
4
report three
4

Similar Publications

Background: Brain stimulation therapy (BST) has significant potential in treating psychiatric, movement, and cognitive disorders. Given the high prevalence of comorbidities among these disorders, we conducted an umbrella review to comprehensively assess the efficacy of BSTs in treating the core symptoms across these three categories of disorders.

Methods: We systematically searched for meta-analyses and network meta-analyses of randomized controlled trials with sham controls up to September 25, 2024, from databases including PubMed, PsycINFO, Embase, and the Cochrane Library.

View Article and Find Full Text PDF

Background: A considerable proportion (21%) of patients with common variable immunodeficiency (CVID) suffers from depression. These subjects are characterized by reduced naïve T cells and a premature T cell senescence similar to that of patients with major depressive disorder (MDD). It is known that T cells are essential for limbic system development/function.

View Article and Find Full Text PDF

Transcranial Alternating Current Stimulation (tACS) for Major Depressive Disorder.

Psychiatr Ann

November 2022

Harvard Medical School, Department of Psychiatry, Boston, Massachusetts (JAC, PC); Division of Neuropsychiatry, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts (JAC, PC); Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (JR, FF); Carolina Center for Neurostimulation, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (JR, FF); Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts (PC); Center for Anxiety and Traumatic Stress Disorders, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts (PC); Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (FF); Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (FF); Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (FF); and Neuroscience Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (FF).

The 21st century has brought forth major advancements in device-based treatments for psychiatric disorders such as major depressive disorder (MDD). One of the most exciting technologies on the rise in this field is transcranial alternating current stimulation (tACS). The small but rapidly growing body of knowledge on tACS suggests that this wearable, low-cost, noninvasive neuromodulation method could provide a safe and effective alternative, or augmentation, to pharmacological interventions for MDD.

View Article and Find Full Text PDF

Background: Evidence suggests that death anxiety is a transdiagnostic construct underlying numerous anxiety-related conditions. A previous phase I trial of Overcome Death Anxiety (ODA), a novel online stand-alone psychological intervention to reduce death anxiety, demonstrated preliminary evidence of efficacy and acceptability in a clinical population. However, this trial was limited by a small sample size (=20).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!